nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0459	0.0787	CbGeAlD
Cinolazepam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0398	0.0683	CbGeAlD
Cinolazepam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0383	0.0657	CbGeAlD
Cinolazepam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0358	0.0614	CbGeAlD
Cinolazepam—GABRR2—nerve—amyotrophic lateral sclerosis	0.031	0.0532	CbGeAlD
Cinolazepam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0299	0.0512	CbGeAlD
Cinolazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0137	0.0235	CbGeAlD
Cinolazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0125	0.0215	CbGeAlD
Cinolazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0121	0.0207	CbGeAlD
Cinolazepam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00805	0.0138	CbGeAlD
Cinolazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00785	0.0135	CbGeAlD
Cinolazepam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00777	0.0133	CbGeAlD
Cinolazepam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00748	0.0128	CbGeAlD
Cinolazepam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00726	0.0124	CbGeAlD
Cinolazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00718	0.0123	CbGeAlD
Cinolazepam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00705	0.0121	CbGeAlD
Cinolazepam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00698	0.012	CbGeAlD
Cinolazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00694	0.0119	CbGeAlD
Cinolazepam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00679	0.0116	CbGeAlD
Cinolazepam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00672	0.0115	CbGeAlD
Cinolazepam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00667	0.0114	CbGeAlD
Cinolazepam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00657	0.0113	CbGeAlD
Cinolazepam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00647	0.0111	CbGeAlD
Cinolazepam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00647	0.0111	CbGeAlD
Cinolazepam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00584	0.01	CbGeAlD
Cinolazepam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00562	0.00964	CbGeAlD
Cinolazepam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00562	0.00964	CbGeAlD
Cinolazepam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.0055	0.00942	CbGeAlD
Cinolazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00548	0.00939	CbGeAlD
Cinolazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00548	0.00939	CbGeAlD
Cinolazepam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00545	0.00934	CbGeAlD
Cinolazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00542	0.0093	CbGeAlD
Cinolazepam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00541	0.00928	CbGeAlD
Cinolazepam—GABRG3—brain—amyotrophic lateral sclerosis	0.00539	0.00924	CbGeAlD
Cinolazepam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00529	0.00907	CbGeAlD
Cinolazepam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00525	0.009	CbGeAlD
Cinolazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00522	0.00895	CbGeAlD
Cinolazepam—GABRR1—brain—amyotrophic lateral sclerosis	0.00514	0.00881	CbGeAlD
Cinolazepam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00513	0.00879	CbGeAlD
Cinolazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00505	0.00865	CbGeAlD
Cinolazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00488	0.00837	CbGeAlD
Cinolazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00488	0.00837	CbGeAlD
Cinolazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00486	0.00833	CbGeAlD
Cinolazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00484	0.00829	CbGeAlD
Cinolazepam—GABRD—brain—amyotrophic lateral sclerosis	0.00446	0.00765	CbGeAlD
Cinolazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00431	0.00739	CbGeAlD
Cinolazepam—GABRG1—brain—amyotrophic lateral sclerosis	0.0043	0.00737	CbGeAlD
Cinolazepam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00421	0.00721	CbGeAlD
Cinolazepam—GABRB1—brain—amyotrophic lateral sclerosis	0.00417	0.00714	CbGeAlD
Cinolazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00415	0.0071	CbGeAlD
Cinolazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00412	0.00705	CbGeAlD
Cinolazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00412	0.00705	CbGeAlD
Cinolazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00396	0.00679	CbGeAlD
Cinolazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00396	0.00679	CbGeAlD
Cinolazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00387	0.00664	CbGeAlD
Cinolazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00387	0.00664	CbGeAlD
Cinolazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00386	0.00661	CbGeAlD
Cinolazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00376	0.00644	CbGeAlD
Cinolazepam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00375	0.00643	CbGeAlD
Cinolazepam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00373	0.00639	CbGeAlD
Cinolazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00363	0.00623	CbGeAlD
Cinolazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00362	0.0062	CbGeAlD
Cinolazepam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.00359	0.00615	CbGeAlD
Cinolazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00354	0.00606	CbGeAlD
Cinolazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.0035	0.006	CbGeAlD
Cinolazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00342	0.00586	CbGeAlD
Cinolazepam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00316	0.00542	CbGeAlD
Cinolazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.00315	0.00539	CbGeAlD
Cinolazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.00315	0.00539	CbGeAlD
Cinolazepam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00304	0.00522	CbGeAlD
Cinolazepam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00297	0.0051	CbGeAlD
Cinolazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.00287	0.00493	CbGeAlD
Cinolazepam—GABRE—brain—amyotrophic lateral sclerosis	0.00285	0.00488	CbGeAlD
Cinolazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.00278	0.00476	CbGeAlD
Cinolazepam—GABRA2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00255	0.00612	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00253	0.00608	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00251	0.00603	CbGpPWpGaD
Cinolazepam—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00249	0.00597	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00242	0.00581	CbGpPWpGaD
Cinolazepam—GABRB3—brain—amyotrophic lateral sclerosis	0.00242	0.00414	CbGeAlD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0024	0.00575	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00239	0.00573	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00232	0.00556	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00224	0.00537	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00221	0.00531	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00221	0.0053	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00217	0.00522	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00215	0.00515	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00214	0.00513	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.00512	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00211	0.00506	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00211	0.00506	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00207	0.00497	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00206	0.00494	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00205	0.00491	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00204	0.00489	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00202	0.00485	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00198	0.00475	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00197	0.00474	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00195	0.00469	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00194	0.00467	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00194	0.00466	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00192	0.00462	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00191	0.00459	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0019	0.00457	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0019	0.00457	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0019	0.00457	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0019	0.00456	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00186	0.00447	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00186	0.00446	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00184	0.00441	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00182	0.00437	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00182	0.00436	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00182	0.00436	CbGpPWpGaD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0018	0.00432	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00179	0.0043	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00178	0.00426	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00177	0.00424	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00176	0.00422	CbGpPWpGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00175	0.0042	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00173	0.00416	CbGpPWpGaD
Cinolazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00172	0.00412	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00171	0.00412	CbGpPWpGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0017	0.00407	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00169	0.00407	CbGpPWpGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00169	0.00405	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00168	0.00403	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00166	0.00399	CbGpPWpGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00165	0.00395	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00164	0.00393	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00163	0.00391	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.00388	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00161	0.00387	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00161	0.00386	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00158	0.0038	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00158	0.0038	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00157	0.00376	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00156	0.00374	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00155	0.00371	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00153	0.00368	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00152	0.00365	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00151	0.00363	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0015	0.00359	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00149	0.00359	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.00359	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00149	0.00357	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00149	0.00357	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00148	0.00355	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00147	0.00353	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00147	0.00353	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00146	0.00351	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00146	0.0035	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00146	0.0035	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00144	0.00346	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00144	0.00345	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00144	0.00345	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00143	0.00343	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00143	0.00343	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00141	0.00339	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0014	0.00336	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00139	0.00335	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.00334	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00139	0.00334	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00139	0.00333	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00138	0.00331	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00137	0.0033	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00136	0.00328	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00135	0.00325	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00135	0.00325	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00135	0.00323	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.0032	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00133	0.00319	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00133	0.00319	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00133	0.00318	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00131	0.00316	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00131	0.00315	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0013	0.00312	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00129	0.0031	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00127	0.00305	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00127	0.00305	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00126	0.00303	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00126	0.00302	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00126	0.00302	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00298	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00124	0.00297	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00124	0.00297	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00123	0.00296	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00123	0.00295	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00123	0.00295	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00123	0.00295	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00122	0.00294	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00122	0.00293	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00122	0.00293	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00121	0.00291	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00121	0.00291	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0012	0.00288	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0012	0.00288	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00119	0.00286	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00118	0.00284	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00118	0.00284	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00118	0.00283	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00118	0.00283	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00117	0.00282	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00117	0.00281	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00117	0.00281	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00116	0.00279	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00115	0.00276	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00115	0.00276	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00115	0.00275	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00115	0.00275	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00114	0.00274	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00113	0.00272	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00113	0.00271	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00113	0.00271	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00112	0.0027	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00112	0.00269	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00112	0.00269	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00111	0.00266	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0011	0.00264	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0011	0.00264	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00109	0.00262	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00109	0.00262	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00108	0.0026	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.0026	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00107	0.00258	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00107	0.00257	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00106	0.00255	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00106	0.00254	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00105	0.00252	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00105	0.00251	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00104	0.00251	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00104	0.00249	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00104	0.00249	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00246	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00102	0.00245	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00102	0.00244	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00101	0.00242	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00101	0.00241	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00101	0.00241	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00101	0.00241	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000989	0.00237	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000972	0.00233	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000966	0.00232	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000964	0.00231	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000964	0.00231	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000948	0.00228	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000946	0.00227	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000939	0.00225	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000937	0.00225	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000937	0.00225	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000922	0.00221	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00092	0.00221	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00092	0.00221	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000919	0.00221	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000906	0.00218	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000904	0.00217	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000904	0.00217	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000902	0.00217	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000898	0.00216	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000898	0.00216	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000897	0.00215	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000887	0.00213	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000882	0.00212	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000882	0.00212	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000881	0.00212	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000879	0.00211	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000865	0.00208	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000859	0.00206	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000835	0.002	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000829	0.00199	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00082	0.00197	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000806	0.00193	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0008	0.00192	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000789	0.00189	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000786	0.00189	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000784	0.00188	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000784	0.00188	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000771	0.00185	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000771	0.00185	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000756	0.00182	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000748	0.0018	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000748	0.0018	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000724	0.00174	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000713	0.00171	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000699	0.00168	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000687	0.00165	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000667	0.0016	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000635	0.00152	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000616	0.00148	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000616	0.00148	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00061	0.00146	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000607	0.00146	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000607	0.00146	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000592	0.00142	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000582	0.0014	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000572	0.00137	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000568	0.00136	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000558	0.00134	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000549	0.00132	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000541	0.0013	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000518	0.00124	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000518	0.00124	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000504	0.00121	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000504	0.00121	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000494	0.00119	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000494	0.00119	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000487	0.00117	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000486	0.00117	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000486	0.00117	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000483	0.00116	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000483	0.00116	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000474	0.00114	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000474	0.00114	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000462	0.00111	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000449	0.00108	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000441	0.00106	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000433	0.00104	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00043	0.00103	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000423	0.00101	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000414	0.000995	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000414	0.000995	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000394	0.000946	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000369	0.000887	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000317	0.000761	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000269	0.000646	CbGpPWpGaD
